mozavaptan has been researched along with lithium chloride in 1 studies
| Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (lithium chloride) | Trials (lithium chloride) | Recent Studies (post-2010) (lithium chloride) |
|---|---|---|---|---|---|
| 165 | 8 | 24 | 3,883 | 45 | 1,152 |
| Protein | Taxonomy | mozavaptan (IC50) | lithium chloride (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 6.53 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arata, T; Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sanada, S; Sasaki, S; Sato, A; Satomi, S; Suzuki, M | 1 |
1 other study(ies) available for mozavaptan and lithium chloride
| Article | Year |
|---|---|
Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzazepines; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Drug Synergism; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Lithium Chloride; Male; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2007 |